Resveratrol - Evaluation of anticancer activity;Resweratrol - Ocena działania przeciwnowotworowego

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 362-364

  Szumiło, Justyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Animal model; Cancer; Chemoprevention; Resveratrol; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMICAL AGENT; POLYPHENOL; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; FOOD COMPOSITION; GRAPE; NONHUMAN; RAT; RED WINE; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; EVALUATION STUDIES; HUMANS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PLANT EXTRACTS; STILBENES; WINE;

EID: 33645665961     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Aggarwal B.B., Bhardwaj A., Aggarwal R.S. i wsp.: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res., 2004, 24, 2783-2840.
2. Asensi M., Medina I., Ortega A. i wsp.: Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free. Radic. Biol. Med., 2002, 33, 387-398.
3. Baer-Dubowska W.: Nieodżywcze składniki roślin w chemioprewencji nowotworów oraz chorób serca i układu kra̧żenia. Farm. Pol., 2000, 56, 1064-1070.
4. Banejree S., Bueso-Ramos C., Aggarwal B.B.: Suppression of 7-12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2 and matrix metalloprotease 9. Cancer Res., 2002, 62, 4945-4954.
5. Bhat K.P., Lantvit D., Christov K. i wsp.: Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res., 2001, 61, 7456-7463.
6. Bove K., Lincoln D.W., Tsan M.F.: Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun., 2002, 291, 1001-1005.
7. Breinholt V.M., Molck A.M., Svendsen G.W. i wsp.: Effects of dietary antioxidants and 2-amino-3-methylimidazo[4,5-f]-quinoline (IQ) on preneoplastic lesions and on oxidative damage, hormonal status, and detoxification capacity in the rat. Food Chem. Toxicol., 2003, 41, 1315-1323.
8. Caltagirone S., Rossi C., Poggi A. i wsp.: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer, 2000, 87, 595-600.
9. Carbo N.: Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun., 1999, 254, 739-743.
10. Chen Y., Tseng S.H., Lai H.S. i wsp.: Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery, 2004, 136, 57-66.
11. Gescher A.J., Steward W.P.: Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 953-957.
12. Hecht S.S., Kenney P.M., Wang M. i wsp.: Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis in A/J mice. Cancer Lett., 1999, 137, 123-130.
13. Jang M., Cai L., Udeani G.O. i wsp.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275, 218-220.
14. Juan M.E., Vinardell M.P., Planas J.M.: The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr., 2002, 132, 257-260.
15. Kapadia G.J., Azuine M.A., Tokuda H. i wsp.: Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res., 2002, 45, 499-505.
16. Kimura Y., Okuda H.: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J. Nutr., 2001, 131, 1844-1849.
17. Li Z.G., Hong T., Shimada Y. i wsp.: Suppression of N- nitrosomethylbenzylamine (NMBA)-induced esophageal tumor/genesis in F344 rats by resveratrol. Carcinogenesis, 2002, 23, 1531-1536.
18. Liu H.S., Pan C.E., Yang W. i wsp.: Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J. Gastroenterol., 2003, 9, 1474-1476,
19. Provinciali M., Re F., Donnini A. i wsp.: Effect of resveratrol on the development of spontaneous mammary tumors In HER-2/neu transgenic mice. Int. J. Cancer, 2005, 115, 36-45.
20. Revel A., Raanani H., Younglai E. i wsp.: Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol., 2003, 23, 255-261.
21. Min+ mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int. J. Cancer, 2005, 115, 194-201.
22. Sato M., Pei R.J., Yuri T. i wsp.: Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett., 2003, 202, 137-145.
23. Schneider Y., Duranton B., Gosse F. i wsp.: Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr. Cancer, 2001, 39, 102-107.
24. Soleas G.J., Grass L., Josephy P.D. i wsp.: A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin. Biochem., 2002, 35, 119-124.
25. Tessitore L., Davit A., Sarotto I. i wsp.: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression. Carcinogenesis, 2000, 21, 1619-1622.
26. Tseng S.H., Lin S.M., Chen J.C. i wsp.: Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer. Res., 2004, 10, 2190-2202.
27. Wu S.L., Sun Z.J., Yu L. i wsp.: Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J. Gastroenterol., 2004, 10, 3048-3052.
28. Yu L., Sun Z.J., Wu S.L. i wsp.: Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J. Gastroenterol., 2003, 9, 2341-2343.
29. Zhou H.B., Chen J.J., Wang W.X. i wsp.: Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J. Gastroenterol., 2005, 11, 280-284.
30. Ziegler C.C., Rainwater L., Whelan J. i wsp.: Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. J. Nutr., 2004, 134, 5-10.